Reported Tuberculosis in the United States, 2020
Table 51. Tuberculosis Cases and Percentages, by Completion of Tuberculosis Therapy (COT): Reporting Areas, 20181
See Surveillance Slide #53
| Reporting Area | Total Cases | Therapy ≤1 Year Indicated2,3,4 | Therapy >1 Year Indicated3,5 | |||
|---|---|---|---|---|---|---|
| No. | COT ≤1 year(%) | COT(%) | No. | COT(%) | ||
| United States | 9,006 | 7,359 | (89.1) | (95.5) | 507 | (95.3) |
| Alabama | 91 | 81 | (85.2) | (93.8) | 2 | (100.0) |
| Alaska | 63 | 57 | (93.0) | (96.5) | 2 | (100.0) |
| Arizona | 178 | 134 | (85.1) | (93.3) | 11 | (100.0) |
| Arkansas | 76 | 69 | (76.8) | (89.9) | 2 | (0.0) |
| California | 2,097 | 1,713 | (88.2) | (96.5) | 95 | (94.7) |
| Colorado | 64 | 58 | (96.6) | (100.0) | 2 | (100.0) |
| Connecticut | 51 | 43 | (100.0) | (100.0) | 3 | (100.0) |
| Delaware | 22 | 18 | (83.3) | (88.9) | 1 | (100.0) |
| District of Columbia | 36 | 27 | (92.6) | (92.6) | 2 | (100.0) |
| Florida | 591 | 501 | (97.2) | (99.0) | 23 | (100.0) |
| Georgia | 270 | 222 | (92.8) | (97.3) | 18 | (94.4) |
| Hawaii | 120 | 101 | (94.1) | (100.0) | 2 | (100.0) |
| Idaho | 15 | 8 | (75.0) | (87.5) | 4 | (100.0) |
| Illinois | 319 | 257 | (89.5) | (96.1) | 21 | (90.5) |
| Indiana | 116 | 96 | (95.8) | (99.0) | 8 | (100.0) |
| Iowa | 49 | 42 | (95.2) | (100.0) | 2 | (100.0) |
| Kansas | 28 | 23 | (73.9) | (73.9) | 2 | (0.0) |
| Kentucky | 65 | 47 | (85.1) | (93.6) | 3 | (100.0) |
| Louisiana | 105 | 91 | (75.8) | (90.1) | 3 | (66.7) |
| Maine | 14 | 13 | (84.6) | (84.6) | 1 | (100.0) |
| Maryland | 208 | 173 | (77.5) | (89.6) | 13 | (100.0) |
| Massachusetts | 200 | 169 | (81.7) | (95.3) | 10 | (100.0) |
| Michigan | 108 | 85 | (95.3) | (96.5) | 9 | (100.0) |
| Minnesota | 172 | 139 | (92.1) | (97.1) | 26 | (100.0) |
| Mississippi | 80 | 65 | (93.8) | (96.9) | 1 | (100.0) |
| Missouri | 80 | 66 | (74.2) | (75.8) | 8 | (87.5) |
| Montana | 5 | 3 | (100.0) | (100.0) | 0 | … |
| Nebraska | 27 | 24 | (79.2) | (87.5) | 1 | (100.0) |
| Nevada | 69 | 58 | (100.0) | (100.0) | 5 | (100.0) |
| New Hampshire | 12 | 10 | (100.0) | (100.0) | 1 | (100.0) |
| New Jersey | 291 | 230 | (91.7) | (96.5) | 24 | (100.0) |
| New Mexico | 39 | 34 | (91.2) | (97.1) | 2 | (100.0) |
| New York State6 | 191 | 141 | (95.7) | (98.6) | 13 | (100.0) |
| New York City | 553 | 447 | (93.1) | (95.7) | 43 | (93.0) |
| North Carolina | 196 | 170 | (86.5) | (92.4) | 8 | (100.0) |
| North Dakota | 13 | 11 | (81.8) | (100.0) | 0 | … |
| Ohio | 178 | 149 | (85.9) | (95.3) | 10 | (90.0) |
| Oklahoma | 74 | 58 | (94.8) | (98.3) | 6 | (100.0) |
| Oregon | 81 | 71 | (95.8) | (100.0) | 6 | (100.0) |
| Pennsylvania | 213 | 173 | (84.4) | (94.8) | 11 | (100.0) |
| Rhode Island | 20 | 14 | (78.6) | (100.0) | 2 | (100.0) |
| South Carolina | 86 | 61 | (93.4) | (100.0) | 6 | (100.0) |
| South Dakota | 12 | 11 | (72.7) | (81.8) | 0 | … |
| Tennessee | 139 | 108 | (92.6) | (94.4) | 8 | (87.5) |
| Texas | 1,116 | 909 | (85.0) | (92.7) | 50 | (90.0) |
| Utah | 18 | 13 | (100.0) | (100.0) | 4 | (100.0) |
| Vermont | 5 | 5 | (40.0) | (40.0) | 0 | … |
| Virginia | 204 | 168 | (94.0) | (97.6) | 14 | (100.0) |
| Washington | 190 | 152 | (94.1) | (97.4) | 14 | (100.0) |
| West Virginia | 6 | 5 | (60.0) | (80.0) | 0 | … |
| Wisconsin | 49 | 35 | (85.7) | (100.0) | 5 | (100.0) |
| Wyoming | 1 | 1 | (100.0) | (100.0) | 0 | … |
| American Samoa7 | 2 | 2 | (50.0) | (50.0) | 0 | … |
| Fed. States of Micronesia7 | 104 | 98 | (90.8) | (93.9) | 4 | (100.0) |
| Guam7 | 71 | 62 | (85.5) | (88.7) | 1 | (100.0) |
| Marshall Islands7 | 367 | 349 | (67.0) | (69.6) | 1 | (100.0) |
| Northern Mariana Islands7 | 47 | 41 | (90.2) | (92.7) | 1 | (100.0) |
| Puerto Rico7 | 28 | 19 | (78.9) | (89.5) | 3 | (100.0) |
| Palau7 | 17 | 11 | (90.9) | (100.0) | 2 | (50.0) |
| U.S. Virgin Islands7 | 1 | 1 | 0 | 0 | 0 | … |
1Most recent year for which data are available.
2Initial isolate susceptible to rifampin (n = 5,562) or susceptibility unknown (n = 89); culture negative (n = 1,395); culture status unknown (n = 295).
3Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia).
4Therapy ≤1 year indicated in persons alive at diagnosis with an initial regimen of one or more drugs prescribed, who did not die within one year of initiating therapy. Excludes persons with initial isolate rifampin resistant, or patient with bone and joint disease, meningeal disease or disease of the central nervous system, or pediatric patient (age <15) with miliary disease or positive blood culture or a positive nucleic acid amplification test on a blood specimen, and those who moved out of the country within one year of initiating treatment.
5Initial isolate rifampin resistant, or patient with meningeal disease or bone and joint disease, or disease of the central nervous system, or pediatric patient (age <15) with miliary disease or positive blood culture or a positive nucleic acid amplification test on a blood specimen, and those who did not move out of the country or die during treatment.
6Excludes New York City.
7Not included in U.S. totals.
Note: Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.
Zero % (0.0) denotes <0.05%.
See Technical Notes for description of completion of therapy calculation.
